home · filing · 0001193125-22-311947
8-K
filed December 27, 2022, 6:59 PM ET
ticker CLDI
CIK 0001855485
leadership
confidence high
sentiment neutral
materiality 0.50
First Light Acquisition Group co-CEO Bill Weber resigns; Thomas Vecchiolla becomes sole CEO and Chairman
Calidi Biotherapeutics, Inc.
Bill Weber resigned as co-CEO, Director, and Chairman effective Dec 21, 2022; no disagreement cited.
Thomas A. Vecchiolla appointed sole CEO and Chairman, effective Dec 22, 2022.
Weber's departure reduces leadership to a single CEO structure.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Bill Weber
co-Chief Executive Officer, Director and Chairman of the Board
CLDI ·
Calidi Biotherapeutics, Inc.
Effective 2022-12-21
Successor Thomas A. Vecchiolla
Filed December 27, 2022, 6:59 PM ET
On December 21, 2022, Bill Weber resigned from his position as co-Chief Executive Officer, Director and Chairman of the Board
Effective 2022-12-22
Filed December 27, 2022, 6:59 PM ET
Effective as of December 22, 2022, Thomas A. Vecchiolla will serve as sole Chief Executive Officer and Chairman of the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bill Weber resigned as co-Chief Executive Officer, Director and Chairman of the Board at Calidi Biotherapeutics, Inc..
Action resigned
Role co-Chief Executive Officer, Director and Chairman of the Board
Exact text from the filing
On December 21, 2022, Bill Weber resigned from his position as co-Chief Executive Officer, Director and Chairman of the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Thomas A. Vecchiolla was appointed as sole Chief Executive Officer and Chairman of the Board at Calidi Biotherapeutics, Inc..
Action appointed
Role sole Chief Executive Officer and Chairman of the Board
Exact text from the filing
Effective as of December 22, 2022, Thomas A. Vecchiolla will serve as sole Chief Executive Officer and Chairman of the Board.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-22-311947
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.